Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,040 results that match your search.22,040 results
  • Practitioners in the US and Canada face the prospect of exciting changes in the future as courts tackle fundamental issues about the limits of trade mark and copyright protection. James Nurton reports
  • ? China: The World Summit on Intellectual Property is to be held in Beijing in April 2003. It will be sponsored jointly by WIPO and the Chinese Government.
  • Attorneys in the US have welcomed important changes to the USPTO reexamination practice, passed by the Senate in October. Under the changes, the reexamination process should prove much more attractive, particularly to third parties.
  • Alice Turinas and Bart Showalter compare data protection regulations in the US and Europe and reveal some of the pitfalls that await companies doing business internationally
  • Pursuant to the Mexican Law of Industrial Property, the owner or an authorized licensee of a registered mark must use that mark in commerce. If the mark is not used within a three year period, although it will remain in full force until its renewal time, it will be also contestable, and in consequence any interested third party could file a cancellation action against it on non-use basis.
  • An action to revoke its patent on the drug Videx EC threatens to limit further Bristol-Myers Squibb's (BMS) rights to sell Aids medicines in Thailand. Three Aids patients and the Foundation for Consumers, a local group, claim that the US pharmaceutical company did not invent the drug and so should not be allowed to own the rights to it in Thailand. According to the plaintiffs, the drug is a product of collaboration between BMS and the US National Institutes of Health (NIH).
  • Sam Mamudi, Copenhagen
  • As European politicians consider fundamental reforms to patent protection, one of the key questions they have to address is how to make the system more efficient. In particular, some critics believe Europe needs to look to the US model to improve its effectiveness. In a special MIP debate, Koos Rasser argues that the European patent system as it exists today is substantially inferior to that of the US, while Simon Mounteney says that, though not perfect, Europe offers many benefits to applicants
  • Rosella L Fernandez, assistant director, and Emma C Francisco, director general, Philippines Bureau of Patents